ADA-SCID

Alessandro Aiuti1, Shimon Slavin, Memet Aker

  • 1San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Milan, Italy.

Science (New York, N.Y.)
|June 29, 2002
PubMed
概括

血造干细胞 (HSC) 基因治疗缺少腺氨酸酶 (ADA) 的严重综合免疫缺陷 (SCID) 是有前途的. 一项采用非骨髓衰变条件的新方案导致两名患者的持续移植和改善免疫功能.